Alisa Tokareva

ORCID: 0000-0001-5918-9045 · 7 papers in corpus
other 2025
International journal of molecular sciences ·doi:10.3390/ijms262411824

Gestational diabetes mellitus (GDM) and macrosomia are crucial for improving maternal and neonatal outcomes. Molecular dysregulations can manifest long before clinical symptoms appear. This study aimed to leverage first-trimester serum lipi…

diagnostic-accuracy 2024
·doi:10.20944/preprints202405.1326.v1

Endometriosis is a prevalent chronic inflammatory disease characterized by a considerable delay between initial symptoms and diagnosis through surgery. The pressing need for a timely, non-invasive diagnostic solution underscores the focus o…

diagnostic-accuracy 2024
Biomolecules ·doi:10.3390/biom14080899

Endometriosis is a prevalent chronic inflammatory disease characterized by a considerable delay between initial symptoms and diagnosis through surgery. The pressing need for a timely, non-invasive diagnostic solution underscores the focus o…

observational 2023
International journal of molecular sciences ·doi:10.3390/ijms241813787

The COVID-19 pandemic has raised questions about indirect impact in pregnant women on the development of their future children. Investigating the characteristics of lipid metabolism in the "mother-placenta-fetus" system can give information…

observational 2022
International journal of molecular sciences ·doi:10.3390/ijms24010010

Follicular fluid is an important component of follicle growth and development. Negative effects of COVID-19 on follicular function are still open. The aim of this work was to study the features of the lipid profile of follicular fluid and e…

other 2021
Scientific reports ·doi:10.1038/s41598-021-89859-0

Uterine fibroids (UF) is the most common (about 70% cases) type of gynecological disease, with the recurrence rate varying from 11 to 40%. Because UF has no distinct symptomatology and is often asymptomatic, the specific and sensitive diagn…

diagnostic-accuracy 2020
International journal of molecular sciences ·doi:10.3390/ijms21124568

Current methods for the intraoperative determination of breast cancer margins commonly suffer from the insufficient accuracy, specificity and/or low speed of analysis, increasing the time and cost of operation as well the risk of cancer rec…